Immunogen | Attività Correnti



Attività Correnti Cambiamento Data
AbbVie USD 29.06B 523M 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Amgen USD 29.06B 1.17B 2025-12
Astellas Pharma JPY 1.44T 72.43B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Exelixis USD 1.44B 41.03M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
Intrexon USD 23.72M 45.04M 2024-06
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
MacroGenics USD 232.09M 27.15M 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.95B 8.99B 2025-12


Immunogen Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.